Neil B. Desai, MD,MHS

University of Texas Southwestern

Radiation oncologist involved in genioturinary malignancy practice and clinical trials investigations at UT Southwestern, with latter involvement at NRG cooperative group and at local institution in PI roles. Current interests in gene expression biomarker categorization of benefit from ADT intensity with RT in PCa and with imaging response to treatment in order to refine RT intensity in PCa.

Disclosure information not submitted.

Presentation(s):

• Introduction

  Friday, April 28, 2023
  2:20 PM – 2:22 PM CST

• Q & A

  Friday, April 28, 2023
  2:58 PM – 3:04 PM CST